$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

$sbra Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000149229817000018 Filed on May 08, 2017

Income Statement

Concept	2017 Q1	2016 Q1
Revenue	$62.65M	$62.56M
YoY Change	0.15%	12.57%
Cost Of Revenue	$2.400M	$1.400M
YoY Change	71.43%
Gross Profit	$60.20M	$61.10M
YoY Change	-1.47%
Gross Profit Margin	96.09%	97.67%
Selling, General & Admin	$7.900M	$7.200M
YoY Change	9.72%	-10.0%
% of Gross Profit	13.12%	11.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$19.14M	$17.77M
YoY Change	7.72%	25.55%
% of Gross Profit	31.79%	29.08%
Operating Expenses	$27.00M	$25.00M
YoY Change	8.0%	13.12%
Operating Profit	$33.20M	$36.10M
YoY Change	-8.03%
Interest Expense	-$15.80M	-$16.90M
YoY Change	-6.51%	21.58%
% of Operating Profit	-47.59%	-46.81%
Other Income/Expense, Net	$2.129M	$0.00
YoY Change		-100.0%
Pretax Income	$19.01M	-$15.70M
YoY Change	-221.09%	-180.93%
Income Tax	$220.0K
% Of Pretax Income	1.16%
Net Earnings	$18.82M	-$15.71M
YoY Change	-219.81%	-180.78%
Net Earnings / Revenue	30.04%	-25.11%
Basic Earnings Per Share	$0.25	-$0.28
Diluted Earnings Per Share	$0.25	-$0.28
COMMON SHARES
Basic Shares Outstanding	65.35M shares	65.25M shares
Diluted Shares Outstanding	65.92M shares	65.25M shares

Balance Sheet

Concept	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.80M	$9.100M
YoY Change	40.66%	116.67%
Cash & Equivalents	$12.81M	$9.133M
Short-Term Investments
Other Short-Term Assets	$126.0M	$119.5M
YoY Change	5.44%	16.81%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$138.8M	$128.6M
YoY Change	7.93%	20.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.994B	$1.924B
YoY Change	3.63%	17.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$11.20M	$84.20M
YoY Change	-86.7%	1120.29%
Total Long-Term Assets	$2.101B	$2.306B
YoY Change	-8.86%	21.47%
TOTAL ASSETS
Total Short-Term Assets	$138.8M	$128.6M
Total Long-Term Assets	$2.101B	$2.306B
Total Assets	$2.240B	$2.434B
YoY Change	-7.97%	21.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$33.40M	$28.30M
YoY Change	18.02%	19.41%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$33.40M	$28.30M
YoY Change	18.02%	19.41%
LONG-TERM LIABILITIES
Long-Term Debt	$1.202B	$1.398B
YoY Change	-13.99%	33.32%
Other Long-Term Liabilities		$300.0K
YoY Change
Total Long-Term Liabilities	$1.202B	$1.398B
YoY Change	-14.01%	33.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$33.40M	$28.30M
Total Long-Term Liabilities	$1.202B	$1.398B
Total Liabilities	$1.236B	$1.427B
YoY Change	-13.38%	33.04%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$654.0K	$653.0K
YoY Change	0.15%	10.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.004B	$1.007B
YoY Change
Total Liabilities & Shareholders Equity	$2.240B	$2.434B
YoY Change	-7.97%	21.43%

Cashflow Statement

Concept	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	$18.82M	-$15.71M
YoY Change	-219.81%	-180.78%
Depreciation, Depletion And Amortization	$19.14M	$17.77M
YoY Change	7.72%	25.55%
Cash From Operating Activities	$31.59M	$24.73M
YoY Change	27.75%	0.1%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.000M	$2.000M
YoY Change	-150.0%	-132.26%
Cash From Investing Activities	-$961.0K	$1.964M
YoY Change	-148.93%	-131.49%
FINANCING ACTIVITIES
Cash Dividend Paid	$29.99M	$29.30M
YoY Change	2.36%	14.14%
Common Stock Issuance & Retirement, Net	-$3.224M	-$1.274M
YoY Change	153.06%	-83.21%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$43.35M	-$25.12M
YoY Change	72.55%	-66.98%
NET CHANGE
Cash From Operating Activities	$31.59M	$24.73M
Cash From Investing Activities	-$961.0K	$1.964M
Cash From Financing Activities	-$43.35M	-$25.12M
Net Change In Cash	-$12.72M	$1.568M
YoY Change	-911.29%	-102.72%
FREE CASH FLOW
Cash From Operating Activities	$31.59M	$24.73M
Capital Expenditures	$0.00
Free Cash Flow	$31.59M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	sbra	Convertible Preferred Stock Conversion Price ConvertiblePreferredStockConversionPrice	25.00
CY2016Q1	sbra	Gain Loss On Extinguishment Of Debt Noncash Portion GainLossOnExtinguishmentOfDebtNoncashPortion	-556000	USD
CY2017Q1	sbra	Gain Loss On Extinguishment Of Debt Noncash Portion GainLossOnExtinguishmentOfDebtNoncashPortion	0	USD
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001492298
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	65410668	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	Sabra Health Care REIT, Inc.
CY2016Q4	sbra	Allowance For Straight Line Rent AllowanceForStraightLineRent	3700000	USD
CY2017Q1	sbra	Allowance For Straight Line Rent AllowanceForStraightLineRent	1900000	USD
CY2016Q1	sbra	Business Combination Contingent Consideration Changein Fair Valueof Liability BusinessCombinationContingentConsiderationChangeinFairValueofLiability	0	USD
CY2017Q1	sbra	Business Combination Contingent Consideration Changein Fair Valueof Liability BusinessCombinationContingentConsiderationChangeinFairValueofLiability	822000	USD
CY2016Q1	sbra	Income Loss From Subsidiaries IncomeLossFromSubsidiaries	0	USD
CY2017Q1	sbra	Income Loss From Subsidiaries IncomeLossFromSubsidiaries	0	USD
CY2016Q1	sbra	Interest Income InterestIncome	5332000	USD
CY2017Q1	sbra	Interest Income InterestIncome	1945000	USD
CY2017Q1	sbra	Investments Weighted Average Contractual Rate InvestmentsWeightedAverageContractualRate	0.110
CY2017Q1	sbra	Investments Weighted Average Effective Rate InvestmentsWeightedAverageEffectiveRate	0.109
CY2016Q4	sbra	Loan Receivable Face Value LoanReceivableFaceValue	53484000	USD
CY2017Q1	sbra	Loan Receivable Face Value LoanReceivableFaceValue	54029000	USD
CY2017Q1	sbra	Loans And Leases Receivable Effective Interest Rate LoansAndLeasesReceivableEffectiveInterestRate	0.091
CY2017Q1	sbra	Loans And Leases Receivable Fixed Interest Rate LoansAndLeasesReceivableFixedInterestRate	0.094
CY2017Q1	sbra	Loans And Leases Receivable Number Of Loans LoansAndLeasesReceivableNumberOfLoans	10	loan
CY2016Q4	sbra	Loansreceivableandotherinvestmentsnet Loansreceivableandotherinvestmentsnet	96036000	USD
CY2016Q1	sbra	Number Of Investment Grading Companies NumberOfInvestmentGradingCompanies	2	investment_grading_company
CY2017Q1	sbra	Loansreceivableandotherinvestmentsnet Loansreceivableandotherinvestmentsnet	96489000	USD
CY2017Q1	sbra	Numberof Investments NumberofInvestments	22	loan
CY2017Q1	sbra	Numberof Real Estate Properties Transitioned NumberofRealEstatePropertiesTransitioned	8	Property
CY2017Q1	sbra	Numberof Real Estate Properties Transitioned NumberofRealEstatePropertiesTransitioned	8	Property
CY2017Q1	sbra	Operating Leases Weighted Average Lease Expiration Period OperatingLeasesWeightedAverageLeaseExpirationPeriod	P9Y
CY2017Q1	sbra	Paymentofcontingentconsideration Paymentofcontingentconsideration	0	USD
CY2016Q1	sbra	Payments For Proceeds From Intercompany Financing Investing Activities PaymentsForProceedsFromIntercompanyFinancingInvestingActivities	0	USD
CY2017Q1	sbra	Payments For Proceeds From Intercompany Financing Investing Activities PaymentsForProceedsFromIntercompanyFinancingInvestingActivities	0	USD
CY2016Q1	sbra	Payments Of Distributions To Parent PaymentsOfDistributionsToParent	0	USD
CY2017Q1	sbra	Payments Of Distributions To Parent PaymentsOfDistributionsToParent	0	USD
CY2016Q4	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	45190000	USD
CY2017Q1	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	46451000	USD
CY2016Q4	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	44882000	USD
CY2017Q1	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	46079000	USD
CY2017Q1	sbra	Preferred Equity Investment Weighted Average Contractual Rate PreferredEquityInvestmentWeightedAverageContractualRate	0.129
CY2017Q1	sbra	Preferred Equity Investment Weighted Average Effective Rate PreferredEquityInvestmentWeightedAverageEffectiveRate	0.129
CY2017Q1	sbra	Preferred Equity Investments Number PreferredEquityInvestmentsNumber	12	loan
CY2016Q4	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets Net PrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet	125279000	USD
CY2017Q1	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets Net PrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet	126007000	USD
CY2016Q1	sbra	Proceeds From Distributions To Parent Investing Activities ProceedsFromDistributionsToParentInvestingActivities	0	USD
CY2017Q1	sbra	Proceeds From Distributions To Parent Investing Activities ProceedsFromDistributionsToParentInvestingActivities	0	USD
CY2016Q1	sbra	Proceeds From Loans Payable ProceedsFromLoansPayable	69360000	USD
CY2017Q1	sbra	Proceeds From Loans Payable ProceedsFromLoansPayable	0	USD
CY2017Q1	sbra	Real Estate Investments Joint Ventures Number RealEstateInvestmentsJointVenturesNumber	0	Investment
CY2016Q1	sbra	Tenant Fees And Services Revenue TenantFeesAndServicesRevenue	1915000	USD
CY2017Q1	sbra	Tenant Fees And Services Revenue TenantFeesAndServicesRevenue	3481000	USD
CY2016Q1	sbra	Total Expenses TotalExpenses	73144000	USD
CY2017Q1	sbra	Total Expenses TotalExpenses	45988000	USD
CY2016Q1	sbra	Total Other Income Expense TotalOtherIncomeExpense	-5158000	USD
CY2017Q1	sbra	Total Other Income Expense TotalOtherIncomeExpense	2129000	USD
CY2017Q1	sbra	Variable Interest Entity Number Of Entities VariableInterestEntityNumberOfEntities	2	variable_interest_entity
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	39639000	USD
CY2017Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	33397000	USD
CY2016Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	192201000	USD
CY2017Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	203641000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1798000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1628000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1208862000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1208907000	USD
CY2016Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1938000	USD
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2860000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3200000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3300000	USD
CY2016Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	27000	USD
CY2017Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	28000	USD
CY2016Q4	us-gaap	Assets Assets	2265919000	USD
CY2017Q1	us-gaap	Assets Assets	2240126000	USD
CY2016Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2017Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2073000	USD
CY2016Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1983769000	USD
CY2017Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1981783000	USD
CY2017Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	487000	USD
CY2017Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15674000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1200000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1221000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1300000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1277000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7434000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9133000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25663000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12814000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1568000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12870000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.41
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65285614	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65410668	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65285614	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65410668	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	653000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	654000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17776000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18993000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-32000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-32000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-17808000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	18961000	USD
CY2013Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1.7864	shares
CY2017Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1218537000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17766000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19137000	USD
CY2016Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2017Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2017Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2016Q4	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	10524000	USD
CY2017Q1	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	9912000	USD
CY2016Q4	us-gaap	Derivative Assets DerivativeAssets	11240000	USD
CY2017Q1	us-gaap	Derivative Assets DerivativeAssets	10908000	USD
CY2016Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2017Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2016Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	716000	USD
CY2017Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	996000	USD
CY2016Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2016Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	716000	USD
CY2017Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	996000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	11240000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	10908000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	716000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	996000	USD
CY2016Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	716000	USD
CY2017Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	996000	USD
CY2016Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2017Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2016Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2017Q1	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	USD
CY2016Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	100000	USD
CY2017Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	100000	USD
CY2016Q1	us-gaap	Dividends Common Stock DividendsCommonStock	26859000	USD
CY2017Q1	us-gaap	Dividends Common Stock DividendsCommonStock	27702000	USD
CY2016Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	2561000	USD
CY2017Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	2561000	USD
CY2016Q4	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2017Q1	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2016Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2017Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2016Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	131000	USD
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	21000	USD
CY2016Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	85196000	USD
CY2017Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	85622000	USD
CY2016Q1	us-gaap	Gain Loss On Sale Of Properties Net Of Applicable Income Taxes GainLossOnSaleOfPropertiesNetOfApplicableIncomeTaxes	-4602000	USD
CY2017Q1	us-gaap	Gain Loss On Sale Of Properties Net Of Applicable Income Taxes GainLossOnSaleOfPropertiesNetOfApplicableIncomeTaxes	0	USD
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-556000	USD
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4714000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6873000	USD
CY2016Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	29811000	USD
CY2017Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-15743000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	18791000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5430000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4605000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5900000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1414000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	1154000	USD
CY2017Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	731000	USD
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	565837	shares
CY2016Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	16918000	USD
CY2017Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	15788000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	19459000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	18127000	USD
CY2016Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	13800000	USD
CY2017Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	9600000	USD
CY2017Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	100108000	USD
CY2016Q4	us-gaap	Investments Investments	96036000	USD
CY2017Q1	us-gaap	Investments Investments	96489000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2017Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2016Q1	us-gaap	Investments In And Advances To Affiliates At Fair Value Period Increase Decrease InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease	0	USD
CY2016Q4	us-gaap	Land Land	220042000	USD
CY2017Q1	us-gaap	Land Land	220117000	USD
CY2016Q4	us-gaap	Land Improvements LandImprovements	3744000	USD
CY2017Q1	us-gaap	Land Improvements LandImprovements	3475000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	1250310000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	1235773000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2265919000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2240126000	USD
CY2016Q4	us-gaap	Line Of Credit LineOfCredit	26000000	USD
CY2017Q1	us-gaap	Line Of Credit LineOfCredit	17000000	USD
CY2016Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	2750000	USD
CY2017Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	4096000	USD
CY2017Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	54029000	USD
CY2016Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	50846000	USD
CY2017Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	50038000	USD
CY2016Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	335673000	USD
CY2017Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	336592000	USD
CY2016Q4	us-gaap	Loans Receivable Net LoansReceivableNet	53596000	USD
CY2017Q1	us-gaap	Loans Receivable Net LoansReceivableNet	54134000	USD
CY2017Q1	us-gaap	Long Term Debt LongTermDebt	1202376000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	326880000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	858304000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	21560000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	4412000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4270000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3111000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	35000	USD
CY2017Q1	us-gaap	Minority Interest MinorityInterest	3000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25122000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-43347000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1964000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-961000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24726000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31438000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-15711000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	18823000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-32000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-32000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18272000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16262000	USD
CY2016Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1412000	USD
CY2017Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2420000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	2124303000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	155591000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	195307000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	225378000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	219300000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	212860000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	1115867000	USD
CY2016Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	55312000	USD
CY2017Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	57224000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-573000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-558000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2065000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	170000	USD
CY2016Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-222000	USD
CY2017Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-26000	USD
CY2016Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	USD
CY2017Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2129000	USD
CY2016Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	29301000	USD
CY2017Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	29993000	USD
CY2016Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5885000	USD
CY2017Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	109000	USD
CY2016Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	474000	USD
CY2017Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	508000	USD
CY2017Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	520000	USD
CY2016Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	984000	USD
CY2017Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	51000	USD
CY2016Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	5850000	USD
CY2017Q1	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	0	USD
CY2013Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.07125
CY2016Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2561000	USD
CY2017Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2561000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	25.00
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5750000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5750000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5800000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5750000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5750000	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	58000	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	58000	USD
CY2016Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	8874000	USD
CY2017Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	118000	USD
CY2016Q1	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-1274000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-3224000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	138300000	USD
CY2016Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2017Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2016Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-57000000	USD
CY2017Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-9000000	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	398000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	USD
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2523000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1770000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	282812000	USD
CY2017Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	297405000	USD
CY2016Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2292751000	USD
CY2017Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2290997000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	2009939000	USD
CY2017Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1993592000	USD
CY2016Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1022000	USD
CY2017Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1021000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9002000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9151000	USD
CY2016Q1	us-gaap	Revenues Revenues	62559000	USD
CY2017Q1	us-gaap	Revenues Revenues	62650000	USD
CY2013Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25.00
CY2016Q4	us-gaap	Secured Debt SecuredDebt	160752000	USD
CY2017Q1	us-gaap	Secured Debt SecuredDebt	159905000	USD
CY2016Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	2700000	USD
CY2017Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	2000000	USD
CY2016Q4	us-gaap	Senior Notes SeniorNotes	700000000	USD
CY2017Q1	us-gaap	Senior Notes SeniorNotes	700000000	USD
CY2017Q1	us-gaap	Straight Line Rent StraightLineRent	4607000	USD
CY2016Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-1492000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1818000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2588000	USD
CY2017Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	2600000	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1015574000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	1004350000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1053876000	USD
CY2016Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1007498000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1015609000	USD
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1004353000	USD
CY2016Q1	us-gaap	Straight Line Rent StraightLineRent	5593000	USD
CY2017Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	728000	USD
CY2016Q4	us-gaap	Unsecured Debt UnsecuredDebt	688246000	USD
CY2017Q1	us-gaap	Unsecured Debt UnsecuredDebt	688879000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65248203	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65920486	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65248203	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65354649	shares
CY2017Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001492298-17-000018-index-headers.html	Edgar Link	pending
0001492298-17-000018-index.html	Edgar Link	pending
0001492298-17-000018.txt	Edgar Link	pending
0001492298-17-000018-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sbra-20170331.xml	Edgar Link	completed
sbra-20170331.xsd	Edgar Link	pending
sbra-20170331_cal.xml	Edgar Link	unprocessable
sbra-20170331_def.xml	Edgar Link	unprocessable
sbra-20170331_lab.xml	Edgar Link	unprocessable
sbra-20170331_pre.xml	Edgar Link	unprocessable
sbra10q2017q1.htm	Edgar Link	pending
sbraex101genesislease.htm	Edgar Link	pending
sbraex102moubuyout.htm	Edgar Link	pending
sbraex103mousale.htm	Edgar Link	pending
sbraex104dispositions.htm	Edgar Link	pending
sbraex105mousaletransferof.htm	Edgar Link	pending
sbraex106genesisguarantyof.htm	Edgar Link	pending
sbraex107genesisleaseamend.htm	Edgar Link	pending
sbraex1212017q1.htm	Edgar Link	pending
sbraex3112017q1.htm	Edgar Link	pending
sbraex3122017q1.htm	Edgar Link	pending
sbraex3212017q1.htm	Edgar Link	pending
sbraex3222017q1.htm	Edgar Link	pending
sbraex41seventhsupplementa.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

2017 Q1 Form 10-Q Financial Statement

#000149229817000018 Filed on May 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA Sabra Health Care REIT, Inc. Stock $sbra

2017 Q1 Form 10-Q Financial Statement

#000149229817000018 Filed on May 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra